Earnings To Watch: Cytokinetics Inc (CYTK) Reports Q3 2024 Result [Yahoo! Finance]
Cytokinetics, Incorporated (CYTK)
Last cytokinetics, incorporated earnings: 3/3 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.cytokinetics.com/investor-overview
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $1.20 million, and the earnings are expected to come in at -$1.26 per share. The full year 2024's revenue is expected to be $7.34 million and the earnings are expected to be -$5.17 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 7 Warning Signs with CYTK. Over the past 90 days, revenue estimates for Cytokinetics Inc ( NASDAQ:CYTK ) for the full year 2024 have declined from $14.38 million to $7.34 million, and for 2025, from $78.52 million to $68.03 million. Earnings estimates have also seen a downward revision, from -$4.48 per share to -$5.17 per share for the full year 2024, and from -$4.25 per share to -$5.04 per share for 2025. In the previous quarter of 2024-06-30, Cytokinetics Inc's ( NASDAQ:CYTK ) actual revenue was $0.25 million, which missed analysts' revenue expectations of $0.92 million by -72.99%. Cytokinetics Inc's ( NASDAQ:CYTK ) actual earnings were -$1.31 per sha
Show less
Read more
Impact Snapshot
Event Time:
CYTK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYTK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYTK alerts
High impacting Cytokinetics, Incorporated news events
Weekly update
A roundup of the hottest topics
CYTK
News
- Cytokinetics to Announce Fourth Quarter Results on February 27, 2025GlobeNewswire
- Cytokinetics, Incorporated (NASDAQ: CYTK) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $67.00 price target on the stock, down previously from $70.00.MarketBeat
- Cytokinetics Names Robert E. Landry to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Cytokinetics, Incorporated (NASDAQ: CYTK) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.MarketBeat
- Cytokinetics Names Robert E. Landry to Board of DirectorsGlobeNewswire
CYTK
Earnings
- 11/6/24 - Miss
CYTK
Sec Filings
- 2/12/25 - Form SCHEDULE
- 2/11/25 - Form 4
- 2/11/25 - Form 3
- CYTK's page on the SEC website